Related Experiment Video
Updated: Jul 2, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Candida infection in HIV positive patients 1985-2007
Christian Traeder1, Susann Kowoll, Keikawus Arastéh
1Vivantes, Auguste-Viktoria-Hospital, Berlin, Germany. christian.traeder@vivantes.de
Abstract:
Infection with Candida species remains a major problem in HIV infected patients. The analysis of over 15,000 hospitalisations (1985-2007) in the AVK cohort shows an increasing incidence of non-albicans species in candida esophagitis. Although our analysis shows a decreasing incidence of opportunistic infections like PCP, cerebral toxoplasmosis and others since the introduction of highly active antiretroviral therapy the incidence of candida esophagitis remains as high as in the years before the HAART era. This observation might reflect the development of resistance against fluconazole and the selection of non-albicans species as a consequence of a long-term prophylactic treatment of HIV+ patients over years.
Insights
Candida esophagitis remains a significant issue for HIV patients, with non-albicans species increasing. This suggests potential antifungal resistance and selection due to long-term prophylaxis in HIV care.
Area of Science:
- Medical Mycology
- Infectious Diseases
- HIV/AIDS Research
Background:
- Candida species infections, particularly Candida esophagitis, pose a persistent challenge for individuals with HIV.
- Highly active antiretroviral therapy (HAART) has reduced many opportunistic infections in HIV patients.
Observation:
- Analysis of over 15,000 hospitalizations (1985-2007) in the AVK cohort revealed an increasing incidence of non-albicans Candida species causing esophagitis.
- Despite the decline in other opportunistic infections post-HAART, Candida esophagitis rates have not decreased.
Findings:
- The incidence of Candida esophagitis in HIV patients has remained high, comparable to pre-HAART era levels.
- There is a notable shift towards non-albicans Candida species in esophagitis cases.
Implications:
- This trend may indicate the emergence of fluconazole resistance in Candida species.
- Long-term prophylactic antifungal treatment in HIV-positive patients could be selecting for non-albicans species.
- Further research into antifungal resistance patterns and treatment strategies for Candida esophagitis in HIV is warranted.
Related Concept Videos
Cryptococcal Meningitis
Candidiasis
Retrovirus Life Cycles
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytomegalovirus Disease

